Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.

Gachoud, David; Bertelli, Claire; Rufer, Nathalie

Gachoud, David; Bertelli, Claire; Rufer, Nathalie.

Afiliação

Gachoud D; Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Bertelli C; Medical Education Unit, School of Medicine, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Rufer N; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Br J Haematol ; 200(2): e25-e27, 2023 01.

Article em En | MEDLINE | ID: mdl-36354067

Assuntos

COVID-19; Humanos; COVID-19/terapia; COVID-19/etiologia; Soroterapia para COVID-19; SARS-CoV-2; Imunização Passiva/efeitos adversos; Linfócitos B; Anticorpos Antivirais; Anticorpos Neutralizantes

Palavras-chave

COVID-19 convalescent plasma; SARS-CoV-2 viral loads; anti-CD20 therapy; immunocompromised

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google